Waters Corporation Common Stock (WAT)
Stock · NYSE · Industrials
$436.95as of 10/16/2026
Price chart
Active signals
WAT Signal Track Record
How signals performed across all stocks →What WAT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | +0.9% | 53% | September 9, 2026 |
| Bollinger Band Breakout | 23 | +1.4% | 52% | September 17, 2026 |
| Bollinger Band Breakdown | 19 | +1.0% | 58% | July 20, 2026 |
| 200-Day Moving Average TouchActive now | 19 | +7.2% | 58% | May 13, 2026 |
| Any 20-session window (baseline) | +1.0% | 55% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About WAT
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 16,000
- Website
- www.waters.com
Fundamentals
- 1-day range
- $431.99$448.39
- Market cap
- $39.24B
- P/E (trailing)
- 260.32
- P/E (forward)
- 26.44
- EPS (trailing)
- $4.00
- Dividend yield
- —
- Beta
- 1.16
- Avg. volume
- 812.5K
- Ex-dividend date
- November 26, 1996
How Waters Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 23, 2026 · via SEC EDGAR / Finnhub
Forecasts
23 analyst ratings
Waters Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- WATWaters Corporation Common Stock$436.95▼ 1.62%Market cap $39.24BP/E 260.32$282.77$454.54
- AAgilent Technologies Inc. Common Stock$172.97▼ 1.47%Market cap $39.92BP/E 34.26$108.35$177.05
- MTDMettler-Toledo International Inc. Common Stock$1,622▼ 1.02%Market cap $28.48BP/E 36.08$1,023$1,620
- BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A$405.85▼ 2.82%Market cap $59.91BP/E —$32.37$66.98
- RVTYRevvity Inc. Common Stock$152.64▼ 1.34%Market cap $12.74BP/E 72.12$81.22$166.25
- BIOBio-Rad Laboratories Inc. Class A Common Stock$353.7▼ 3.05%Market cap $9.16BP/E 43.88$236.73$396.23
- AVTRAvantor Inc. Common Stock$16.42▲ 2.05%Market cap $8.91BP/E —$7.27$16.38
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| WAT Waters Corporation Common Stock | $39.24B | 260.32 | $436.95 | ▼ 1.62% | $282.77$454.54 |
| A Agilent Technologies Inc. Common Stock | $39.92B | 34.26 | $172.97 | ▼ 1.47% | $108.35$177.05 |
| MTD Mettler-Toledo International Inc. Common Stock | $28.48B | 36.08 | $1,622 | ▼ 1.02% | $1,023$1,620 |
| BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A | $59.91B | — | $405.85 | ▼ 2.82% | $32.37$66.98 |
| RVTY Revvity Inc. Common Stock | $12.74B | 72.12 | $152.64 | ▼ 1.34% | $81.22$166.25 |
| BIO Bio-Rad Laboratories Inc. Class A Common Stock | $9.16B | 43.88 | $353.7 | ▼ 3.05% | $236.73$396.23 |
| AVTR Avantor Inc. Common Stock | $8.91B | — | $16.42 | ▲ 2.05% | $7.27$16.38 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Here’s How Much You Would Have Made Owning Waters Stock In The Last 20 Yearsbenzinga · 10/15/2026
- Here's Why You Should Retain WAT Stock in Your Portfolio for NowYahoo · 10/8/2026
- Barclays Maintains Overweight on Waters, Raises Price Target to $500Benzinga · 10/7/2026
- Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue GrowthBenzinga · 10/7/2026
- The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were InvitedBenzinga · 10/6/2026
- CellCarta, Waters Corporation collaborate on companion diagnosticsYahoo · 10/6/2026
- CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics DevelopmentYahoo · 10/5/2026
- FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A BuySeekingAlpha · 10/5/2026
- Waters Corporation Schedules Third Quarter 2026 Earnings Conference CallYahoo · 10/1/2026
Insider Activity
Insider Actions →- Heather Knight · September 30, 2026 · Grant57
- Wei Jiang · September 30, 2026 · Grant57
- Christopher A. Kuebler · August 6, 2026 · Option Exercise3.6K @ $136.43
- Christopher A. Kuebler · August 6, 2026 · Sale3.6K @ $397.94
- Heather Knight · June 30, 2026 · Grant63
- Wei Jiang · June 30, 2026 · Grant67
- Robert L. Carpio III · June 24, 2026 · Tax Withholding189 @ $369.18
- Amol Chaubal · May 12, 2026 · Tax Withholding239 @ $352.21
Institutional Ownership
March 31, 2026
- Total shares held
- 87.44M
- Total value held
- $24.57B
- Institutional holders
- 1158
- Unknown8.54M
- Unknown6.38M
- Unknown4.66M
- Unknown4.63M
- Unknown4.36M
- Unknown3.21M
- Unknown2.65M
- Unknown2.17M
- Unknown2.12M
- Unknown1.64M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Waters Launches AI Link for LC-MS Workflows
Waters Corporation introduced AI Link, a tool designed to advance AI-enabled LC-MS workflows from research to release. This product launch highlights the company's focus on integrating artificial intelligence into its laboratory solutions. Additionally, TD Cowen raised its price target to $515, reflecting continued analyst interest in the stock's potential.
Waters Launches AI Link for LC-MS Workflows. Waters Corporation introduced AI Link, a tool designed to advance AI-enabled LC-MS workflows from research to release. This product launch highlights the company's focus on integrating artificial intelligence into its laboratory solutions. Additionally, TD Cowen raised its price target to $515, reflecting continued analyst interest in the stock's potential.